topicOlive Leaf Cholesterol Meta-Analysis
claimThe declining CVD mortality rate that was observed remained stable in the last years or even increased in some populations [,].
evidence level2
citationLauwers Stef (2026)
sourceEvaluation of the effect of olive extracts on blood pressure and cardiovascular health markers in adults: Findings from a double-blind, placebo-controlled, randomised trial
topicOlive Leaf Cholesterol Meta-Analysis
claim5 6 7 8 Poor management of factors, such as diet, physical activity, blood lipids, and blood pressure, will increase the risk of developing CVD as a 20 mmHg increase in systolic blood pressure (SBP) is associated with a doubled risk of death from CVD [,].
evidence level2
citationLauwers Stef (2026)
sourceEvaluation of the effect of olive extracts on blood pressure and cardiovascular health markers in adults: Findings from a double-blind, placebo-controlled, randomised trial
topicOlive Leaf Cholesterol Meta-Analysis
claimCVD risk factors often occur clustered, as hypertension is linked to dyslipidaemia, impaired glucose tolerance and type 2 diabetes [,].
evidence level2
citationLauwers Stef (2026)
sourceEvaluation of the effect of olive extracts on blood pressure and cardiovascular health markers in adults: Findings from a double-blind, placebo-controlled, randomised trial
topicOlive Leaf Cholesterol Meta-Analysis
claim1 2 3 4 Over the past few decades, remarkable progress has been made in developing strategies to lower the incidence of cardiovascular diseases (CVD).
evidence level2
citationLauwers Stef (2026)
sourceEvaluation of the effect of olive extracts on blood pressure and cardiovascular health markers in adults: Findings from a double-blind, placebo-controlled, randomised trial
topicOlive Leaf Cholesterol Meta-Analysis
claimEditorial: Preventing cardiovascular complications of type 2 diabetes, volume II.
evidence level4
citationDi Pietrantonio N (2026)
sourceEditorial: Preventing cardiovascular complications of type 2 diabetes, volume II.